Diagnostic Evaluation of Sarcopenia in Elderly Patients

Completed

• Conditions: Sarcopenia

• Registration Number: NCT04451005
• Lead Sponsor: University of Sao Paulo

Brief Summary

Sarcopenia is a generalized progressive skeletal muscle disorder that represents a related physiological vulnerability that is associated with or increases the likelihood of adverse outcomes, including falls, fractures, physical disability and death. The parameters used to assess sarcopenia in clinical practice have limited use due to their custody.

In this perspective, this study proposes or develops a tool for the diagnosis of having sarcopenia with a specific boa and a sensitive boa.

low cost and useful.

Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected

This study was of clinical importance, due to sarcopenia and a relevant factor, and could lead to consequences and poor prognosis in patients with gold, and it was not a method of clinical practice to properly endorse body composition in this population.

Detailed Description

Sarcopenia is a progressive and generalized skeletal muscle disorder that represents an age-related physiological vulnerability that is associated with an increased likelihood of adverse outcomes, including falls, fractures, physical disability and mortality. The parameters used to assess sarcopenia in clinical practice have limited use due to its cost.

In this perspective, this study proposes the development of a tool for the diagnosis of having sarcopenia with good specificity and good sensitivity and of low cost and useful.

Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected. After signing the informed consent, sarcopenia will be assessed using the reference method (DXA) and anthropometry. The data obtained by the methods are treated statistically to obtain correlation and thus a new tool for the evaluation of sarcopenia patients in the elderly can be developed.

This study is of clinical importance, as sarcopenia is a relevant factor and can lead to consequences and poor prognosis in elderly patients, and there is no low-cost method in clinical practice to properly assess body composition in this population.

Study Timeline

• Study Start: 2016-05-06
• Primary Completion: 2018-05-06
• Study Completion: 2019-12-10
• Status Verified: 2020-06
• Study First Submitted: 2020-06-02
• Study First Submitted QC: 2020-06-25
• Last Update Submitted: 2020-06-25
• Study First Posted: 2020-06-30
• Last Update Posted: 2020-06-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 403

Inclusion Criteria

• Age ≥ 60 years
• Sign free and informed consent;
• Demonstrate interest, conditions and availability to participate in all procedures included in the study protocol;

Exclusion Criteria

• Refusal to participate;
• Patients who have not undergone cognitive testing;
• Physical amputation;
• Patients undergoing interventional treatment for sarcopenia;

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sarcopenia in the elderly	12 months	Evaluation of sarcopenia in the elderly

Secondary Outcome Measures

Name	Time	Method
Development of a new tool for sarcopenia screening	12 months	Development of a new tool for sarcopenia screening